Nephros News

Benchmark Co. Maintains Nephros(NEPH.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsAug 23 06:36 ET

Nephros's Strong Fundamentals and Growth Prospects Merit a Buy Rating

TipRanksAug 10 07:19 ET

Nephros Analyst Ratings

BenzingaMay 15 07:57 ET

Nephros: Buy Rating Affirmed Amid Solid Performance and Growth Prospects

TipRanksMay 11 15:10 ET

Nephros Poised for Growth: A Buy Recommendation Amid Expansion and Optimized Operations

TipRanksMar 9 15:25 ET

Nephros Analyst Ratings

BenzingaMar 8 13:47 ET

Nephros Poised for Growth: Strong Financials and Strategic Initiatives Secure Buy Rating

TipRanksMar 8 11:20 ET

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Nephros (NEPH)

TipRanksSep 12, 2023 07:10 ET

Maxim Group Sticks to Their Buy Rating for Nephros (NEPH)

TipRanksAug 11, 2023 07:35 ET

Nephros (NEPH) Receives a Buy From Maxim Group

TipRanksApr 6, 2023 15:06 ET

Maxim Group Sticks to Its Buy Rating for Nephros (NEPH)

TipRanksMar 10, 2023 15:11 ET

Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Nephros (NEPH)

TipRanksNov 4, 2022 08:05 ET

Analysts Are Bullish on Top Healthcare Stocks: Sanofi (SNYNF), Nephros (NEPH)

TipRanksNov 3, 2022 03:40 ET

B. Riley Securities Lowers Nephros' Price Target to $4.25 From $5.25 Ahead of Q3 Results, Lowers Estimates; Maintains Buy Rating

MT NewswiresOct 19, 2022 09:36 ET

Nephros (NEPH) Receives a Buy from Maxim Group

TipRanksAug 12, 2022 14:40 ET